COVID Trial Diversity: What Participants In The Vaccine Phase III Studies Look Like

 
• By Sue Sutter
  
Diverse population
Vaccine sponsors have adopted different approaches to disclosing diversity data for their Phase III trials. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D